{"product_id":"world-congress-on-controversies-in-ophthalmology-16th-annual-congress-2025","title":"World Congress on Controversies in Ophthalmology 16th Annual Congress 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: ophthalmologists and retina specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate current debates and treatment paradigms in the management of diabetic macular edema (DME), neovascular AMD, and inherited retinal diseases.\u003c\/p\u003e\n\u003cp\u003eAnalyze controversial approaches in glaucoma care, including the choice between medical management, traditional trabeculectomy, and minimally invasive glaucoma surgeries (MIGS).\u003c\/p\u003e\n\u003cp\u003eAssess the evolving role of artificial intelligence, home monitoring, and sustained drug delivery systems in optimizing ophthalmic patient outcomes.\u003c\/p\u003e\n\u003cp\u003eNavigate complex decisions in neuro-ophthalmology, such as the management of idiopathic intracranial hypertension, optic neuritis, and giant cell arteritis.\u003c\/p\u003e\n\u003cp\u003eFormulate evidence-based strategies for surgical interventions, including the management of retinal detachments, macular holes, and symptomatic vitreous floaters.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for ophthalmologists and retina specialists who want updates on controversial treatments, glaucoma surgeries, and novel AMD therapies.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Debate – Multi-Pathway or High Dose Inhibitors Improve DME Biomarkers More Than Previous Treatments\u003c\/p\u003e\n\u003cp\u003e02 Debate – Existing Outcome Measures Are Sufficient to Demonstrate the Efficacy of New Therapies for Inherited Retinal Diseases\u003c\/p\u003e\n\u003cp\u003e03 Debate – Functional Visual Loss is an Organic Disease\u003c\/p\u003e\n\u003cp\u003e04 Debate – Idiopathic Intracranial Hypertension is a Medical, Not Surgical Disease Now\u003c\/p\u003e\n\u003cp\u003e05 Neuro-Ophthalmology – The Efferent Cases\u003c\/p\u003e\n\u003cp\u003e06 The Use of Biosimilars in Uveitis\u003c\/p\u003e\n\u003cp\u003e07 Debate – Prophylactic Laser Retinopexy and Early Pars Plana Vitrectomy (PPV) for Preventing Retinal Detachment (RD) in Acute Retinal Necrosis\u003c\/p\u003e\n\u003cp\u003e08 Debate – HLA-Testing Is Mandatory in the Investigation of Posterior Uveitis\u003c\/p\u003e\n\u003cp\u003e09 Systemic Therapy Is the Best Option to Control Uveitic Macular Edema\u003c\/p\u003e\n\u003cp\u003e10 Debate – Post-Operative Macular Edema May Be Considered and Managed as Uveitis\u003c\/p\u003e\n\u003cp\u003e11 Debate – Inflammatory Choroidal Neovascularization May Be Treated by Anti-VEGFs Alone\u003c\/p\u003e\n\u003cp\u003e12 Debate – Should Glaucoma Be Managed by Comprehensive Ophthalmologists or Glaucoma Specialists\u003c\/p\u003e\n\u003cp\u003e14 Tradition or Innovation Trabeculectomy Versus Minimally Invasive Bleb-Based Surgeries\u003c\/p\u003e\n\u003cp\u003e15 Debate – All Acute Optic Neuritis Patients Require High Dose Steroids\u003c\/p\u003e\n\u003cp\u003e16 Debate – Temporal Artery Ultrasound Should Replace Temporal Artery Biopsy in Giant Cell Arteritis\u003c\/p\u003e\n\u003cp\u003e17 Cases of Optic Neuritis\u003c\/p\u003e\n\u003cp\u003e18 Debate – Phaco Alone Is Better Than Phaco Plus MIGS\u003c\/p\u003e\n\u003cp\u003e19 Debate – Clinicians Decisions Are Better Than AI Decisions in Glaucoma\u003c\/p\u003e\n\u003cp\u003e20 Debate – Complement Inhibition for Geographic Atrophy Has More Benefits Than Risk\u003c\/p\u003e\n\u003cp\u003e21 Debate – Artificial Intelligence (AI) Can Predict the Success of Retinal Detachment Surgery\u003c\/p\u003e\n\u003cp\u003e22 Debate – Heavy Silicone Is the Most Beneficial Adjuvant in the Successful Management of a Retinal Detachment With Proliferative Vitreoretinopathy (PV…\u003c\/p\u003e\n\u003cp\u003e23 Debate – Multifocal (MF) or Extended Depth of Focus (EDOF) IOLs Can Be Employed After Successful Repair of a Macula-Off Retinal Detachment\u003c\/p\u003e\n\u003cp\u003e24 Debate – Functional Outcomes Need to Be Used for Assessment of Treatment Effects of Drugs for Non-Neovascular Age-Related Macular Degeneration…\u003c\/p\u003e\n\u003cp\u003e25 Debate – Photobiomodulation Is a Viable Treatment in Non-Neovascular AMD\u003c\/p\u003e\n\u003cp\u003e26 Debate – Steroid Therapy for DME Is Still Relevant in the Era of New Generation Anti-VEGF Agents\u003c\/p\u003e\n\u003cp\u003e27 Will Oral Therapy for NPDR Be Adopted as Primary Approach to Management of NPDR\u003c\/p\u003e\n\u003cp\u003e28 Debate – Novel Topical Steroids Will Become Standard of Care for Initial Therapy in Mild Diabetic Macular Edema\u003c\/p\u003e\n\u003cp\u003e29 Debate – Inverted Flap Technique Is the Best Surgical Approach for Large Recurrent Macular Holes in High Myopes\u003c\/p\u003e\n\u003cp\u003e30 Debate – In the Setting of a Phakic Macula-On Retinal Detachment, With a Superior Retinal Tear, Comparable Successful Anatomic and Visual Outcomes …\u003c\/p\u003e\n\u003cp\u003e31 Debate – Pars Plana Vitrectomy Is Safe and Effective in the Management of Symptomatic Vitreous Floaters\u003c\/p\u003e\n\u003cp\u003e32 Debate – Blocking More Than VEGF-A Can Help in Improving Visual Acuity in Retinal Disease\u003c\/p\u003e\n\u003cp\u003e33 Impact of Residual Fluid on Treatment Outcomes in Neovascular Age-Related Macular Degeneration\u003c\/p\u003e\n\u003cp\u003e34 Simultaneous GA and CNVMNV – Incidence, Characteristics, and Treatments\u003c\/p\u003e\n\u003cp\u003e35 Cataract Surgery and Anti-VEGF Management\u003c\/p\u003e\n\u003cp\u003e36 Expert Guidence for the Use of New Regimens With Extended Injection Visit Intervals\u003c\/p\u003e\n\u003cp\u003e37 Debate – Will Topical Therapy Become the Standard of Care for Either Prevention or Delay of Myopia Progression\u003c\/p\u003e\n\u003cp\u003e38 Debate – Gene Therapy for nAMD Will Be the Preferred Therapy in the Future\u003c\/p\u003e\n\u003cp\u003e39 Debate – Sustained Drug Delivery Has a Potential to Be a Significant Treatment Option for Neovascular AMD and Other Retinal Diseases\u003c\/p\u003e\n\u003cp\u003e40 Debate – New Generation Anti-VEGF Agents Are Specifically Beneficial for Pigment Epithelial Detachment\u003c\/p\u003e\n\u003cp\u003e41 Does Home Monitoring Have the Potential to Improve Patient Outcome in AMD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405820055748,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/World-Congress-on-Controversies-in-Ophthalmology-16th-Annual-Congress-2025.jpg?v=1784216615","url":"https:\/\/medicalcoursespro.com\/products\/world-congress-on-controversies-in-ophthalmology-16th-annual-congress-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}